PCSK9 and coronary artery disorder: In contrast to the subset of individuals not taking a statin or fibrate in the OHGS, plasma PCSK9 levels were elevated in angiographic CAD cases (385.0±146.9 ng/ml) compared to controls (340.4±125.2 ng/ml, p<0.001) in the EmCB sample.